France's Sanofi has agreed to buy U.S.-based Blueprint Medicines Corporation for over $9 billion to boost its position in ...

Sanofi and Stagecoach Performing Arts are excited to introduce a unique partnership. Selected through a UK-wide audition process, four talented teens living with autoimmune Type 1 diabetes (aT1D) have ...

France's Sanofi has agreed to buy US-based Blueprint Medicines Corp. for over $9 billion to boost its position in rare ...

Recent research from Sanofi highlights the significant impact of Type 1 Diabetes on those living with the condition The song, "Rise Up," shares their experiences of living with the condition and will ...

The head of Saudi budget carrier flyadeal criticised Airbus' handling of delays of narrow-body jets and voiced concerns that ...

This month on pharmaphorum, we explore the history of French pharmaceutical company Sanofi, which was created through many partnerships and acquisitions over a period of 100 years. Sanofi is one ...

Sanofi has added to its rare disease pipeline by licensing an antibody-RNA conjugate (ARC) for facioscapulohumeral muscular dystrophy (FSHD), a genetic muscle disorder, from US biotech miRecule.

Superior Financial Strength, High Growth Trend Stock Priced at High Valuations The Estimates data displayed by Moneycontrol is not a recommendation to buy or sell any securities. Estimates data is ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Sanofi S.A. Annual cash flow by MarketWatch. View SNW net cash flow, operating cash flow, operating expenses and cash dividends. Skip to main content Main Menu Latest News Watchlist Investing Back ...

To help address the impact of COPD on patients and communities, global healthcare companies Sanofi and Regeneron are working together to study the ripple effects of COPD and to help create a ...